Co-Diagnostics Inc (NASDAQ:CODX)

27.62
Delayed Data
As of Aug 05
 -0.76 / -2.68%
Today’s Change
0.85
Today|||52-Week Range
30.99
+2,985.34%
Year-to-Date
Biotech Bonanza - Second Half Outlook
Jul 28 / Seeking Alpha - Paid Partner Content
3 Best-Performing Coronavirus Stocks of 2020 So Far: Are They Buys Now?
Jul 26 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close28.38
Today’s open28.03
Day’s range27.30 - 28.99
Volume2,027,644
Average volume (3 months)5,908,288
Market cap$658.1M
Data as of 3:59pm ET, 08/05/2020

Growth & Valuation

Earnings growth (last year)+26.41%
Earnings growth (this year)+672.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+438.63%
P/E ratioNM
Price/Sales69.78
Price/Book239.29

Competitors

 Today’s
change
Today’s
% change
MORFMorphic Holding Inc+1.36+5.89%
AUTLAutolus Therapeutics...+0.34+2.31%
BCRXBioCryst Pharmaceuti...-0.02-0.47%
CARACara Therapeutics In...-0.03-0.17%
Data as of 4:00pm ET, 08/05/2020

Financials

Next reporting dateAugust 12, 2020
EPS forecast (this quarter)$0.59
Annual revenue (last year)$215.0K
Annual profit (last year)-$6.2M
Net profit margin-2,882.00%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts